The Real-World Burden of Moderate-to-Severe Psoriasis in Patients Under Systemic Treatment from Baltic Countries: Data from the CRYSTAL Observational Study.

Maigi Eisen, Ilona Hartmane, Külli Kingo, Ingmars Mikazans, Tiina Toomson, Karin Toomela, Skaidra Valiukeviciene

Abstract readObservational Study

In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Associations Between Patient Satisfaction with Pharmacist Services, Social Support, and Medication Adherence in Chronic Dermatological Conditions: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026
Article
Medicina (Kaunas, Lithuania) · 2026
Observational
Biological Therapy for Moderate-to-Severe Psoriasis: A 5-Year Analysis of Patients from Lithuania.Medicina (Kaunas, Lithuania) · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maigi EisenCenter of Dermatology and Venereology, The North Estonia Medical Centre, 13419 Tallinn, Estonia.

Ilona HartmaneDepartment of Dermatology and Venereology, Faculty of Medicine, Riga Stradins University, LV-1010 Riga, Latvia.

Külli KingoDepartment of Dermatology and Venereology, University of Tartu, 50090 Tartu, Estonia.

Ingmars MikazansDepartment of Dermatology and Venereology, Faculty of Medicine, Riga Stradins University, LV-1010 Riga, Latvia.

Tiina ToomsonDepartment of Dermatovenerology, Pärnu Central Hospital, 80010 Pärnu, Estonia.

Karin ToomelaAbbVie, 10145 Tallinn, Estonia.

Skaidra ValiukevicieneDepartment of Skin and Venereal Diseases, Medical Academy, Lithuanian University of Health Sciences (LUHS), LT-44307 Kaunas, Lithuania.

Funding

Abbvie Not applicable

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cost of IllnessPsoriasisAdolescentAdultAgedBaltic StatesCross-Sectional StudiesEstoniaFemaleHumansLatviaLithuaniaMaleMiddle AgedQuality of LifeRetrospective Studiesdrug therapypatient-reported outcome measurespsoriasisquality of lifeseverity of illness index

Identifiers

PMID40142208

DOI10.3390/medicina61030397

PMCPMC11943988

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.